HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alberto Piubello Selected Research

Rifampin (Rifampicin)

8/2023High rate of adverse drug reactions with a novel tuberculosis re-treatment regimen combining triple doses of both isoniazid and rifampicin.
5/2023Protocol, rationale and design of BE-PEOPLE (Bedaquiline enhanced exposure prophylaxis for LEprosy in the Comoros): a cluster randomized trial on effectiveness of rifampicin and bedaquiline as post-exposure prophylaxis of leprosy contacts.
1/2023Definitive outcomes in patients with rifampicin-resistant tuberculosis treated in Niger from 2012 to 2019: A retrospective cohort study.
12/2022Safety, effectiveness, and adherence of a short and all-oral treatment regimen for the treatment of rifampicin-resistant tuberculosis in Niger: a study protocol of a pragmatic randomised clinical trial with stratified block randomisation.
11/2022Treatment outcomes for multidrug- and rifampicin-resistant tuberculosis in Central and West Africa: a systematic review and meta-analysis.
11/2022Programmatic management of rifampicin-resistant tuberculosis with standard regimen in Cameroon: a retrospective cohort study.
1/2021High rifampicin-resistant TB cure rates and prevention of severe ototoxicity after replacing the injectable by linezolid in early stage of hearing loss.
6/2020Course of Adverse Events during Short Treatment Regimen in Patients with Rifampicin-Resistant Tuberculosis in Burundi.
3/2020Outcomes of a nine-month regimen for rifampicin-resistant tuberculosis up to 24 months after treatment completion in nine African countries.
1/2020Management of multidrug-resistant tuberculosis with shorter treatment regimen in Niger: Nationwide programmatic achievements.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alberto Piubello Research Topics

Disease

15Tuberculosis (Tuberculoses)
08/2023 - 12/2019
3Ototoxicity
12/2022 - 06/2020
2Hearing Loss (Hearing Impairment)
01/2021 - 06/2020
2Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
01/2020 - 01/2020
1Drug-Related Side Effects and Adverse Reactions
08/2023
1Leprosy (Hansen's Disease)
05/2023

Drug/Important Bio-Agent (IBA)

13Rifampin (Rifampicin)FDA LinkGeneric
08/2023 - 01/2020
2bedaquiline (R207910)IBA
05/2023 - 01/2020
2Linezolid (Zyvox)FDA Link
12/2022 - 01/2021
2FluoroquinolonesIBA
01/2020 - 12/2019
1Isoniazid (Ftivazide)FDA LinkGeneric
08/2023
1KanamycinFDA Link
06/2020

Therapy/Procedure

3Injections
12/2022 - 06/2020
1Retreatment
01/2023
1Continuity of Patient Care
11/2020
1Aftercare (After-Treatment)
03/2020